These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1659136)

  • 21. How do viruses multiply?
    Cooper RJ; Keir HM
    Scott Med J; 1974 Jan; 19(1):31-8. PubMed ID: 4132136
    [No Abstract]   [Full Text] [Related]  

  • 22. [Synthesis of proteins and nucleic components of vaccinia virus].
    Kozlova IA; Mel'nikova LA
    Vopr Virusol; 1966; 11(4):387-92. PubMed ID: 4887655
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective antiviral activity of human interferons on primate oncogenic and neurotropic herpesviruses.
    Daniel MD; Tamulevich R; Bekesi JG; King NW; Falk LA; Silva D; Holland JF
    Int J Cancer; 1981 Jan; 27(1):113-21. PubMed ID: 6166577
    [No Abstract]   [Full Text] [Related]  

  • 24. [Latent infection caused by herpetic viruses].
    Rajcáni J; Santo J
    Vopr Virusol; 1979; (2):99-105. PubMed ID: 219613
    [No Abstract]   [Full Text] [Related]  

  • 25. The antiviral activity against herpes simplex virus of the triterpenoid compounds carbenoxolone sodium and cicloxolone sodium.
    Dargan DJ; Subak-Sharpe JH
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():185-200. PubMed ID: 3025156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of action of interferon.
    Friedman RM; Sonnabend JA
    Arch Intern Med; 1970 Jul; 126(1):51-63. PubMed ID: 5425517
    [No Abstract]   [Full Text] [Related]  

  • 27. Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles.
    Albulescu IC; Kovacikova K; Tas A; Snijder EJ; van Hemert MJ
    Antiviral Res; 2017 Jul; 143():230-236. PubMed ID: 28461070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of cell culture conditions on the inhibition of herpes simplex virus type 1 replication by acyclovir.
    Harmenberg J; Wahren B
    Intervirology; 1982; 17(4):215-21. PubMed ID: 6290415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent progress in research on interferons.
    Lockart RZ
    Prog Med Virol; 1967; 9():451-75. PubMed ID: 4966367
    [No Abstract]   [Full Text] [Related]  

  • 30. Nucleic acid of infectious laryngotracheitis virus.
    Tannock GA
    Nature; 1965 Nov; 208(5011):711-2. PubMed ID: 15270062
    [No Abstract]   [Full Text] [Related]  

  • 31. delta 9-Tetrahydrocannabinol suppresses macrophage extrinsic antiherpesvirus activity.
    Cabral GA; Vasquez R
    Proc Soc Exp Biol Med; 1992 Feb; 199(2):255-63. PubMed ID: 1311105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of insecticides on metabolism and susceptibility of IB-RS-2 cells to foot-and-mouth disease virus (author's transl)].
    Puga FR; La Regina Rodrigues MA
    Arq Inst Biol (Sao Paulo); 1974; 41(3):141-5. PubMed ID: 4374910
    [No Abstract]   [Full Text] [Related]  

  • 33. [Mechanism of interferon action at the molecular level (author's transl)].
    Koide H
    Tanpakushitsu Kakusan Koso; 1976 Apr; 21(4):252-9. PubMed ID: 189356
    [No Abstract]   [Full Text] [Related]  

  • 34. New anti-HSV therapeutics target the helicase-primase complex.
    Crumpacker CS; Schaffer PA
    Nat Med; 2002 Apr; 8(4):327-8. PubMed ID: 11927930
    [No Abstract]   [Full Text] [Related]  

  • 35. 5-(2-Chloroethyl)-2'-deoxyuridine: a potent and selective inhibitor of herpes viruses in vitro and in vivo.
    Rosenwirth B; Griengl H; Wanek E; De Clercq E
    Antiviral Res; 1985; Suppl 1():20-8. PubMed ID: 3002256
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of herpes simplex virus replication by WAY-150138: assembly of capsids depleted of the portal and terminase proteins involved in DNA encapsidation.
    Newcomb WW; Brown JC
    J Virol; 2002 Oct; 76(19):10084-8. PubMed ID: 12208991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of combined acyclovir and vidarabine on infection with herpes simplex virus in vitro and in vivo.
    Park NH; Callahan JG; Pavan-Langston D
    J Infect Dis; 1984 May; 149(5):757-62. PubMed ID: 6327850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon induced inhibition of enveloped viruses.
    Maheshwari RK; Friedman RM
    Prog Clin Biol Res; 1985; 202():297-305. PubMed ID: 2421308
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro antiviral activity of the 6-substituted 2-(3',4'-dichlorophenoxy)-2H-pyrano[2,3-b]pyridines MDL 20,610, MDL 20,646, and MDL 20,957.
    Kenny MT; Dulworth JK; Bargar TM; Torney HL; Graham MC; Manelli AM
    Antimicrob Agents Chemother; 1986 Sep; 30(3):516-8. PubMed ID: 3593475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitors of prostaglandin synthesis as inhibitors of herpes simplex virus replication.
    Newton AA
    Adv Ophthalmol; 1979; 38():58-63. PubMed ID: 230726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.